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Innocent bystanders or chosen collaborators?
Cyclins and cyclin-dependent kinases turn out to have diverse functions,
not all directly concerned with the cell cycle; do they provide a
link between cell-cycle control and other cellular processes?
It is well established that complexes between cyclins and
cyclin-dependent kinases (Cdks) are key regulators of the
eukaryotic cell cycle. Cyclins are proteins related by
sequence similarities in the so-called 'cyclin box', which
bind to, and thereby activate, cyclin-dependent kinases.
Different cyclin-Cdk complexes are involved in the reg-
ulation of different transitions in the cell cycle. The
archetypal Cdk, Cdc2, is predominantly associated with
B-type cyclins, and regulates the transition between G2
and M phases of the cell cycle. Cyclin E-Cdk2 and
cyclin A-Cdk2 complexes are believed to control the
G1-to-S transition and S phase, respectively. Cdk4 and
Cdk6 are associated with the D-type cyclins and are
important for G1 progression.
Recently, however, it has become apparent that, in
addition to direct regulation of the cell cycle, some
cyclins and Cdks are also involved in other biological
processes as diverse as transcription and phosphate
metabolism. This unexpected role for cyclin-Cdk com-
plexes in non-cell-cycle processes raises two important
questions. Why does the cell use one Cdk for more than
one purpose? And do these cyclin-Cdk complexes pro-
vide a link between cell-cycle control and other cellular
processes, such as transcription, DNA repair and
responses to environmental signals?
Cyclin-Cdk complexes in transcriptional regulation
The transcription of a protein-coding gene requires
assembly of a complex involving RNA polymerase II and
various basal transcription factors (TFIIs) at the gene's
promoter region. One of the basal transcription factors
needed for initiation of transcription is TFIIH, which
contains a protein kinase activity that phosphorylates the
carboxy-terminal repeat domain (CTD) of the large sub-
unit of RNA polymerase II [1-3]. The RNA polymerase
II CTD is essential for transcription in vivo, and phos-
phorylation of the CTD is believed to be important for
the release of the transcription complex from the pro-
moter into an elongation mode [4].
TFIIH of the budding yeast, Saccharomyces cerevisiae, is
itself a multi-subunit protein, composed of SSL2, a five
subunit core and a three subunit complex (separately des-
ignated TFIIK) which is the site of TFIIH's CTD-kinase
activity. Several subunits of mammalian TFIIH are known
nucleotide-excision repair proteins, and there is good
evidence that TFIIH is involved in nucleotide-excision
repair. Cell-cycle control has recently been linked to
transcription and DNA repair by the identification of
cycin H and Cdk7 as two of the three subunits of TFIIK
[5-8]. Indeed, microinjection of anti-Cdk7 antibodies
into fibroblasts inhibits both transcription and nucleotide-
excision repair, suggesting that Cdk7 activity may have a
direct role in the nucleotide-excision repair activity asso-
ciated with TFIIH [6], although this result could also be
explained by the known coupling between transcription
and repair.
The finding that cyclin H and Cdk7 are components of
TFIIH is somewhat unexpected, as they were previously
identified as the components of Cdk-activating kinase
(CAK), which phosphorylates the threonine in the acti-
vation loop of other Cdks. Phosphorylation of this threo-
nine - Thrl61 in Cdc2 - is a prerequisite for the
maximal activation of Cdks [9]. Cdk7 is a nuclear protein
and, unlike many regulators of Cdk, the protein level and
activity of Cdk7 does not vary in the cell cycle, apart
from a reduction in GO. Immunoprecipitation studies of
Cdk7 show that CAK contains a third subunit in addi-
tion to cyclin H and Cdk7 [10], which in retrospect is
likely to be the same as the third subunit in TFIIK.
Three groups have recently cloned this third subunit -
called MAT1, for 'M6nage a Trois' - and found it to be
a novel, 36 kDa protein with an amino-terminal zinc
finger of the C3 HC4 , or 'RING', variety [11-13].
Although cyclin H and Cdk7 can form a complex in
vitro, the affinity of this interaction is low. Binding of
MAT1 to cyclin H-Cdk7 stabilizes the complex and
produces higher CAK activity. The RING finger motif
of MAT1 is dispensable for its association with cyclin
H-Cdk7 [11,13]. The equivalent residue in mouse Cdk7
to Thrl61 in Cdc2 is Thrl70, and it appears that phos-
phorylation of this threonine is also required for activa-
tion of CAK. There is, however, no evidence that CAK
autophosphorylates, so CAK must in turn be activated by
another Cdk-like, CAK-activating kinase (CAKAK).
There is evidence that cyclin A-Cdk2 and cyclin
B-Cdc2 can serve as CAKAKs in vitro. Phosphorylation
of Cdk7 residue Thr170 facilitates cyclin H-Cdk7 com-
plex formation, and produces active CAK without a
requirement for MAT1 [12]. Intriguingly, in the presence
of MAT1, phosphorylation of Thrl70 appears to be
dispensable for CAK activity [11,12]. MAT1 thus serves
as both an assembly factor for cyclin H-Cdk7 and a
substitute for phosphorylation by CAKAK.
Unlike cyclin H-Cdk7, the budding yeast homologue
CCL1-KIN28 has CTD kinase activity but does not
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have CAK activity when tested in vitro [5,14]. At present,
the identity of yeast CAK is unknown, but assuming that
CCL1-KIN28 is not CAK, one is apparently forced to
the surprising conclusion that CAK and the TFIIH CTD
kinase are distinct enzymes in yeast, whereas in higher
eukaryotes cycin H-Cdk7 performs both functions. If
true, this would be in stark contrast to what has been
found for most other cell-cycle regulators, where the
number of genes involved at each step has multiplied,
rather than decreased, in progressing from yeast to higher
eukaryotes. In fact, based on this logic one might predict
that other CAKs exist in vertebrates; identification of the
yeast CAK would go a long way to resolving this issue.
One key question is whether the cyclin H-Cdk7-
MAT1 complex is the bona fide CAK in vivo. Most evi-
dence suggests that cyclin H-Cdk7-MAT1 accounts for
the majority of the CAK activity in a cell. Thus, cyclin
H-Cdk7 is the only CAK activity detected during
purification [15,16], and immunodepletion of each of the
three subunits of CAK depletes all the CAK activity in
cell extracts (M. Dore, personal communication). About
half of the cycin H-Cdk7-MAT1 complex is not asso-
ciated with transcription factors [12], suggesting that this
kinase exists in two populations, one functioning as CAK.
and the other in TFIIH (Fig. 1). It is, of course, conceiv-
able that there is a much weaker, or more labile, activity
in the cell that can also serve as CAK. One reason for
believing this is that such an activity could explain how
the Cdc2 in cyclin B-Cdc2, which is in the cytoplasm,
can be phosphorylated on Thrl61, when CAK is in the
nucleus. One possibility is that there is a cytoplasmic
CAK that is associated with membranes and so was
missed during purification.
Cyclin H-Cdk7 also has an atypical substrate specificity
for a cycin-Cdk pair. Cdks generally phosphorylate sub-
strates that have a proline after the target hydroxyamino
acid (Ser/Thr-Pro), but purified CAK can phosphorylate
both Ser/Thr-Pro sites (as in Cdk4 and CTD) and non-
Ser/Thr-Pro sites (such as Thr-His in Cdc2 and Cdk2),
yet cannot phosphorylate conventional Cdk substrates
like histone H1. In the case of cAMP-dependent protein
Fig. 1. Cyclin-CDK complexes in cell-cycle regulation and
transcription.
kinase, selection of the residue following the target
hydroxyamino acid is dictated by a pocket that binds the
P+1 residue. A P+1 pocket is present in all known pro-
tein kinase structures, and in Cdk2 this pocket is designed
to accommodate a proline [17]. The ability of CAK to
phosphorylate Thr161, where the P+1 residue is a histi-
dine, is therefore surprising. If the P+1 pocket in Cdk7 is
like that in Cdk2, this would mean that other interactions
between CAK and the cycin-Cdk complex would have
to override the normally strict requirement for a proline
at P+1. The alternative is that the true cyclin H-Cdk7
substrates are those that contain Ser/Thr-Pro sites, and
that there is another kinase that phosphorylates the
threonine in the activation loops of the Cdks in vivo.
Another possible explanation for this conundrum is that
the CAK in TFIIH is required to activate another
cycin-Cdk pair in the transcription complex, which in
turn is the true CTD kinase. Just such a cyclin-Cdk
complex, which can phosphorylate the CTD, has
recently been identified in the yeast RNA polymerase II
holoenzyme. Partial truncation of the CTD gives rise to
a cold-sensitive phenotype in yeast; mutations in genes
SRB10 and SRB11 suppress this cold-sensitive pheno-
type [18]. SRBIO encodes a Cdk-related protein kinase,
and SRB11 encodes a cyclin-like protein that is most
closely related to cyclin C. SRB10 and SRB11 proteins
form a complex and are associated with the RNA poly-
merase II holoenzyme.
Cells containing mutations in either SRB10 or SRB11
respond poorly to transcriptional induction in vivo.
Moreover, CTD phosphorylation in vitro is reduced
-10-fold when the RNA polymerase II holoenzyme is
derived from cells containing a kinase-inactive mutant
SRB10, suggesting that SRB10-SRBll may be able to
phosphorylate CTD and regulate transcription. When
assayed in vitro, however, no difference in basal and acti-
vated transcriptional activities was observed between
RNA polymerase II containing wild-type or mutant
SRB10, suggesting that the regulatory function of
SRB10-SRB11 may involve more than the phosphoryla-
tion of the CTD, or else that some other factors are
absent from the in vitro purified system. Similarly, TFIIH
containing a kinase-inactive mutant of Cdk7 lacks CTD
kinase activity, yet both basal and activated transcription
in vitro are normal [19]. It will be important to learn
whether cyclin H-Cdk7 and SRB10-SRBll affect each
other's activity in the transcription initiation complex.
Possible homologues of SRB311 and SRB10 are known
in mammalian cells, namely cyclin C (originally cloned
as a G1 cyclin) and its partner Cdk8, respectively [20].
Like cyclin H-Cdk7, cyclin C-Cdk8 may also prove to
have a dual role in cell-cycle and transcriptional control.
Another potential twist of the story is provided by the
recent identification of yet another cyclin-Cdk complex
in yeast, CTK2-CTK1, which can also phosphorylate
CTD [21]. CTK1 is a Cdk-related protein kinase, CTK2
is related to cyclin C, and the CTK2-CTK1 complex is
associated with a novel 32kDa protein, CTK3.
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Cyclin-Cdk complexes in phosphate metabolism
The budding yeast gene PH05 encodes a secreted acid
phosphatase, and its transcription is induced by starvation
for inorganic phosphate. The PHO5 enzyme is positively
regulated by PHO2, PHO4 and PHO81, and negatively
regulated by PHO80 and PHO85. PHO80 is a cyclin
with homology to two yeast cyclins, PCL1 (HSC26) and
PCL2 (ORFD) [22-24], and PHO85 is a Cdk [25]. The
PHO80-PHO85 complex can interact with and phos-
phorylate PHO4, a basic-helix-loop-helix transcription
factor that binds to the PH05 promoter [23]. Phospho-
rylation of PHO4 by PHO80-PHO85 correlates well
with the repression of PH05 expression. Phosphoryla-
tion of PHO4 decreases its binding to the PHOS
upstream activating sequence (UAS), apparently by pre-
venting interaction with the homeodomain protein
PHO2, which is required for PHO4 to bind to the low
affinity PH05 UAS [26].
Like many cyclin-Cdk complexes involved in cell-cycle
control, PHO80-PHO85 can also be inhibited by a
Cdk-inhibitor, PHO81 [27]. Like the p6NK4 family of
Cdk-inhibitors, PHO81 contains ankyrin repeats, and
this region alone is able to inhibit PHO80-PHO85 in
vitro [27]. The region containing the last two ankyrin
repeats has been identified as the minimum region
required for PHO81 function [28]. PHO81 binds to
PHO80, but does not displace PHO85 from PHO80
[26,27], thus differing from the action of pl6INK4 family
Cdk-inhibitors, which bind to Cdk4/6 and preclude
binding of the D-type cyclin.
The reduction of PHO80-PHO85's activity upon phos-
phate starvation could in principle be explained by the
fact that PH081 transcription is induced in response to
phosphate starvation [29]. Intriguingly, however, the
amount of PHO81 associated with PHO80-PHO85 is
the same irrespective of whether the cells are grown in
the presence of high or low phosphate [27], suggesting
that the inhibitory activity of PHO81 towards
PHO80-PHO85 may be regulated post-translationally.
In support of this, PHO81-PHO80 was found to associ-
ate with PHO4 in high phosphate, but the complex dis-
sociates from PHO4 in low phosphate, thus exposing the
PHO4 activation domain [26]. It is therefore possible
that it is only when cells are starved for phosphate that
PHO81 can inhibit the kinase activity of PHO80-
PHO85, leading to decreased phosphorylation of PHO4
and activation of PH05 transcription (Fig. 2).
Interestingly, the same Cdk subunit, PHO85, can also
interact with two other cyclin subunits, PCL1 and PCL2
[22,24]. PCL1-PHO85 and PCL2-PHO85 complexes
appear to be involved in the regulation of G1 phase of
the cell cycle. The expression of PCL1 and PCL2 is con-
trolled by the transcription factor SWI4 and peaks in
G1 [30,31]. The exact roles of PCL1-PHO85 and
PLC2-PHO85 in cell-cycle control are, however,
unclear. PHO85 is non-essential and is required for G1
progression only when the G1 cyclins CLN1 and CLN2
Fig. 2. Cyclin-CDK complexes in cell-cycle regulation and
phosphate metabolism.
are absent [22]. Similarly, deletion of PCL1 or PCL2 has
no effect on the cell cycle, but they are required for G1
progression when CLN1 and CLN2 are absent [22,24]. It
is possible that PCL1-PHO85 and PCL2-PHO85
perform some G1 function that is only manifested when
the other G1 cyclins are absent. The PCL1/PCL2-
PHO85 complexes are likely to have different substrate
targets to CLN-CDC28, as suggested by their different
substrate specificities in vitro (PCL1/PCL2-PHO85 com-
plexes phosphorylate PHO4 and not conventional
CLN-CDC28 substrates [22,24J); this may explain why
overexpression of PH085 cannot complement a CDC28
deletion [25].
Why use one protein kinase for multiple biological
functions?
By existing in different contexts - Cdk7 in CAK or
TFIIH - or in different disguises - PHO85 binding to
PHO80 or PCL1/PCL2 - a single Cdk can thus take
part in cell-cycle control as well as in other, very different
processes, like transcription and phosphate metabolism.
Why would a cell employ one protein kinase to regulate
two unrelated processes? One possibility is that this is
simply an example of efficient protein kinases doing
double duty. For instance, cyclin H-Cdk7 could be used
in different processes because it just happens to be a
constitutively active kinase that is able to phosphorylate
different substrates depending on associations mediated
by the cyclin H-Cdk7-containing holoenzyme. Thus,
cyclin H-Cdk7-MAT1 can phosphorylate Thrl6 or
equivalent residues through a specific association with
cyclin-Cdk complexes, or it can phosphorylate the RNA
polymerase CTD when it is part of TFIIH. However, as
evolution has placed little restriction on genome size,
'good ideas' have generally been reused by gene duplica-
tion, rather than by literally using the same protein for
two purposes.
A far more attractive explanation, therefore, is that these
multifunctional cyclin-Cdks represent a means of coordi-
nating cell-cycle progression with other processes, such
as transcription and DNA repair. For example, the avail-
ability of CAK for Cdk activation or transcription may
decrease when DNA repair is required. Although the
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total level of CAK is constant, the pool of cyclin
H-Cdk7 available for Cdk activation or transcription/
repair may vary under different circumstances. It is possi-
ble that more CAK is recruited into TFIIH complexes
after DNA damage, slowing the cell-cycle progression to
allow time for DNA repair. Another possible substrate for
CAK that would provide a link between DNA repair and
cell-cycle arrest is the tumor suppressor p5 3 , which
interacts with TFIIH [32] via XPB and XPD. It is possi-
ble that when RNA polymerase is stalled at DNA dam-
age sites, Cdk7 in TFIIH phosphorylates p53 and
enhances some p53-mediated function, such as induction
of the Cdk inhibitor p21.
By its ability to bind to different subunits, PH085 shows
how a single Cdk subunit can act in two distinct biologi-
cal processes. It would be of great interest to learn
whether PH085 provides a link between environmental
signals and cell-cycle control. Phosphate starvation may
inhibit the activity of PHO80-PH085 as well as the
activity of PCL1/PCL2-PH085 complexes, perhaps
through the activation of PHO81. Although inhibition
of PH085 alone would not arrest the cell cycle, it may
provide subtle tuning of the cell cycle.
Like PH085, mammalian Cdk5 may also be able to per-
form different functions by associating with different sub-
units. Cdk5 is found complexed with D-type cyclins in
fibroblasts or with a distinct activating subunit, p35, in
postmitotic neuronal cells [33]. The function of the
p35-Cdk5 complex is not yet known, but it is highly
active when isolated from neurons, suggesting that it
plays a role in these postmitotic cells. Unlike other
cyclin-Cdk complexes, which are nuclear, p35-Cdk5 is
localized in the axonal cytoplasm and may phosphorylate
the microtubule-associated protein tau. The role, if any,
of Cdk5 in the mitotic cell cycle is unclear, as a domi-
nant-negative mutant of Cdk5 does not arrest fibroblasts,
unlike the equivalent Cdk2 and Cdc2 mutants. Interest-
ingly, activation of p35-Cdk5 does not require phospho-
rylation of the equivalent residue to Thr161 in Cdc2,
which is reminiscent of the activation of cyclin H-Cdk7
by MAT1. p3 5 has essentially no sequence homology
with the cyclins, raising the issue of whether there are
other examples of non-cyclin activating subunits of Cdks.
The fact that the crystal structure of cyclin A contains
two domains of similar structure but very different
sequence [34] opens up the possibility that proteins like
p35 may also have a cyclin-like structure, even though
they have little homology to cyclins.
In this connection, it is worth noting that cyclins are not
only activating subunits for Cdks but are also targeting
subunits that provide information for proper subcellular
localization, as well as promoting direct interaction of
cyclin-Cdk complexes with individual proteins, thus dic-
tating substrate specificity. This two-subunit system pro-
vides great flexibility and allows a single protein kinase to
function in different ways, while still potentially being
subject to common controls.
Recent years have seen the minimalist idea that the cell
cycle is driven by a single cycin-Cdk complex become
very elaborate. Many cychin-Cdk complexes are now
known to control different points of the cell cycle, each
being regulated by a complex network of protein kinases
and phosphatases and protein kinase inhibitors. We are also
beginning to realize that some cyclin-Cdks have functions
other than in direct cell-cycle control. It is likely that more
non-cell-cycle functions of cyclins and Cdks will be dis-
covered, as to date most of the focus has been on identify-
ing their predicted cell-cycle roles. These delinquent
cycin-Cdk complexes may well provide a link between
cell-cycle progression and other processes in the cell.
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